Stay updated on Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2 to the history. Removed notices about government funding lapse and NIH Clinical Center operating status (Revision: v3.4.1).SummaryDifference0.3%

- Check21 days agoChange DetectedA new revision (v3.4.1) was added, introducing core study sections such as Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow, Eligibility, Arms and Interventions, Study Status, and Study Identification, replacing the previous revision (v3.4.0).SummaryDifference0.7%

- Check28 days agoChange DetectedUI and metadata changes include a new 'Show glossary' option and color-coded highlights for additions and deletions, with the footer updated to Revision: v3.4.0 and the prior v3.3.4 entry removed.SummaryDifference0.4%

- Check64 days agoChange DetectedAdded a new revision entry to the record history: Revision: v3.3.3. The HHS Vulnerability Disclosure item and Revision: v3.3.2 were removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.3.1 removed, representing a minor metadata update to the page history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check93 days agoChange DetectedRevision: v3.3.1 was added and Revision: v3.2.0 was removed. These are minor site versioning updates visible on the page; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial page.